Related references
Note: Only part of the references are listed.Compound Uptake into E. coil Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums
Sarah J. Perlmutter et al.
ACS INFECTIOUS DISEASES (2021)
Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens
Erica N. Parker et al.
NATURE MICROBIOLOGY (2020)
Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data
Kyungmin Huh et al.
CLINICAL INFECTIOUS DISEASES (2020)
Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch
Stephen E. Motika et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health
Camila Fontoura Acosta Ribeiro et al.
ACS INFECTIOUS DISEASES (2020)
Periplasmic Targets for the Development of Effective Antimicrobials against Gram-Negative Bacteria
Ankit Pandeya et al.
ACS INFECTIOUS DISEASES (2020)
Antibacterial Discovery: 21st Century Challenges
Paul S. Hoffman
ANTIBIOTICS-BASEL (2020)
Discovery of Pyrido[2,3-b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV
Yimin Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Polymyxins resistance among Gram-negative pathogens in India
Hariharan Periasamy et al.
LANCET INFECTIOUS DISEASES (2020)
Defining new chemical space for drug penetration into Gram-negative bacteria
Shibin Zhao et al.
NATURE CHEMICAL BIOLOGY (2020)
The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics
Michelle F. Richter et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors
Yangxiong Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase
Logan D. Andrews et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety
Frederick Cohen et al.
CHEMMEDCHEM (2019)
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies
Domiziana Masci et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A new antibiotic selectively kills Gram-negative pathogens
Yu Imai et al.
NATURE (2019)
Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics
Tadeja Lukezic et al.
ACS CHEMICAL BIOLOGY (2019)
Discovery and development of new antibacterial drugs: learning from experience?
Nicole Jackson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Multidrug efflux pumps: structure, function and regulation
Dijun Du et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Cell-based screen for discovering lipopolysaccharide biogenesis inhibitors
Ge Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Riboswitches and Translation Control
Ronald R. Breaker
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Antibacterial Drug Discovery: Some Assembly Required
Ruben Tommasi et al.
ACS INFECTIOUS DISEASES (2018)
Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets
Lauren E. Brooks et al.
MSYSTEMS (2018)
Optimized arylomycins are a new class of Gram-negative antibiotics
Peter A. Smith et al.
NATURE (2018)
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Alexandre P. Zavascki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Predictive compound accumulation rules yield a broad - spectrum antibiotic
Michelle F. Richter et al.
NATURE (2017)
Drug-resistant bacteria ranked
Cassandra Willyard
NATURE (2017)
Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting
Hao Wang et al.
CELL CHEMICAL BIOLOGY (2017)
Access to a Structurally Complex Compound Collection via Ring Distortion of the Alkaloid Sinomenine
Alfredo Garcia et al.
ORGANIC LETTERS (2016)
Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative Activity
Khuloud Takrouri et al.
ACS INFECTIOUS DISEASES (2016)
From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials
Dubravko Jelic et al.
ANTIBIOTICS-BASEL (2016)
Selective small-molecule inhibition of an RNA structural element
John A. Howe et al.
NATURE (2015)
ESKAPEing the labyrinth of antibacterial discovery
Ruben Tommasi et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteria
Elizabeth I. Parkinson et al.
NATURE COMMUNICATIONS (2015)
In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa
Regina Fernandez-Pinar et al.
SCIENTIFIC REPORTS (2015)
General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria
Tony D. Davis et al.
ACS CHEMICAL BIOLOGY (2014)
Synthesis of Complex and Diverse Compounds through Ring Distortion of Abietic Acid
Ryan J. Rafferty et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Synthesis of Bridged Oxafenestranes from Pleuromutilin
Robert W. Hicklin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors
Mohamed Takhi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens
Dean G. Brown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy
Boudewijn L. M. de Jonge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines
Maria Uria-Nickelsen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products
Robert W. Huigens et al.
NATURE CHEMISTRY (2013)
Platforms for antibiotic discovery
Kim Lewis
NATURE REVIEWS DRUG DISCOVERY (2013)
In Vivo Validation of Thymidylate Kinase (TMK) with a Rationally Designed, Selective Antibacterial Compound
Thomas A. Keating et al.
ACS CHEMICAL BIOLOGY (2012)
Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
Nachum Kaplan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature
Keiichi Hiramatsu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Challenges of Antibacterial Discovery
Lynn L. Silver
CLINICAL MICROBIOLOGY REVIEWS (2011)
Challenges of antibacterial discovery revisited
Michael N. Gwynn et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS (2010)
Triclosan Resistance of Pseudomonas aeruginosa PAO1 Is Due to FabV, a Triclosan-Resistant Enoyl-Acyl Carrier Protein Reductase
Lei Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Development of a liquid chromatography/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa
Hongliang Cai et al.
ANALYTICAL BIOCHEMISTRY (2009)
AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli
Cindy Tamae et al.
JOURNAL OF BACTERIOLOGY (2008)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
Physicochemical properties of antibacterial compounds: Implications for drug discovery
Rosemarie O'Shea et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Molecular basis of bacterial outer membrane permeability revisited
H Nikaido
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Discovery of a novel and potent class of fabI-directed antibacterial agents
DJ Payne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors
XY Qiu et al.
PROTEIN SCIENCE (2001)
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI):: 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents
MA Seefeld et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes
MC Sulavik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
